What are the recent financial highlights of BLISS GVS PHARMA LTD?

BLISS GVS PHARMA LTD recently reported a total revenue of ₹809.87 Cr and a net profit margin of 7.36%. These metrics reflect the company’s consistent financial performance.

What is the dividend yield of BLISS GVS PHARMA LTD?

BLISS GVS PHARMA LTD offers a dividend yield of 0.42%, with a dividend rate of ₹0.5 per share.

What are the key financial metrics of BLISS GVS PHARMA LTD?

Key financial metrics include a trailing P/E ratio of 20.337477, forward P/E of , book value of ₹96.164, price-to-book ratio of 1.1906743, and a market capitalization of ₹12.06 billion.

What does BLISS GVS PHARMA LTD do?

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes. In addition, the company offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Blissgvs

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Blissgvs

Latest updates related to Blissgvs

Sr No.	Title	Sentiment
1	Bliss GVS Pharma Limited (NSE:BLISSGVS) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ? Simply Wall St	🔄
2	Here's Why Bliss GVS Pharma (NSE:BLISSGVS) Has Caught The Eye Of Investors Simply Wall St	🔄
3	Insiders were the key beneficiaries as Bliss GVS Pharma Limited's (NSE:BLISSGVS) market cap rises to ₹19b Simply Wall St	🔄
4	Earnings grew faster than the decent 18% CAGR delivered to Bliss GVS Pharma (NSE:BLISSGVS) shareholders over the last three years Simply Wall St	🔄
5	Investors Don't See Light At End Of Bliss GVS Pharma Limited's (NSE:BLISSGVS) Tunnel Simply Wall St	🔄
6	Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now Simply Wall St	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

CUMMINSIND TIPSMUSIC DPABHUSHAN AUSOMENT CHOICEIN SIDDHIKA TRITURBINE RAMRAT BASF STANLEY